CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
A1c Variability Can Predict Coronary Artery Disease in Patients with Type 2 Diabetes with Mean A1c Levels Greater than 7
Eun Ju Lee, You Jeong Kim, Tae Nyun Kim, Tae Ik Kim, Won Kee Lee, Mi-Kyung Kim, Jeong Hyun Park, Byoung Doo Rhee
Endocrinol Metab. 2013;28(2):125-132.   Published online June 18, 2013
DOI: https://doi.org/10.3803/EnM.2013.28.2.125

Excel Download

A1c Variability Can Predict Coronary Artery Disease in Patients with Type 2 Diabetes with Mean A1c Levels Greater than 7
Endocrinology and Metabolism. 2013;28(2):125   Crossref logo
Link1 Link2 Link3

Letter: A1c Variability Can Predict Coronary Artery Disease in Patients with Type 2 Diabetes with Mean A1c Level Greater than 7 (Endocrinol Metab 2013;28:125-32, Eun Ju Lee et al.)
Endocrinology and Metabolism. 2013;28(4):346   Crossref logo
Link1 Link2 Link3

Response: A1c Variability Can Predict Coronary Artery Disease in Patients with Type 2 Diabetes with Mean A1c Level Greater than 7 (Endocrinol Metab 2013;28:125-32, Eun Ju Lee et al.)
Endocrinology and Metabolism. 2013;28(4):348   Crossref logo
Link1 Link2 Link3

Mean and variability of annual haemoglobin A1c are associated with high-risk peripheral artery disease
Diabetes and Vascular Disease Research. 2020;17(3):147916412090903   Crossref logo
Link1 Link2 Link3

Assessment of the Association between Mean Hemoglobin A1c Levels for 5 Years and Coronary Artery Disease by Coronary Angiography in Nondiabetic Patients
Diabetes & Metabolism Journal. 2014;38(1):58   Crossref logo
Link1 Link2 Link3

Greater Dose-Ranging Effects on A1C Levels Than on Glucosuria With LX4211, a Dual Inhibitor of SGLT1 and SGLT2, in Patients With Type 2 Diabetes on Metformin Monotherapy
Diabetes Care. 2014;38(3):431-438   Crossref logo
Link1 Link2

Greater reductions in A1C in type 2 diabetic patients new to therapy with glyburide/metformin tablets as compared to glyburide co-administered with metformin
Diabetes, Obesity and Metabolism. 2003;5(6):424-431   Crossref logo
Link1 Link2 Link3

Patients with Type 2 Diabetes Treated with IDegLira Have a Greater Chance of Achieving A1C Targets Without Hypoglycemia and Weight Gain Than with Basal Insulin or Basal-Bolus Therapy, Irrespective of A1C Target
Canadian Journal of Diabetes. 2018;42(5):S8   Crossref logo
Link1 Link2

932-P: Impacts of Glucose Variability on the Correlation between Estimated Hemoglobin A1c and Measured Glycated Hemoglobin A1c in Patients with Type 2 Diabetes
Diabetes. 2019;68(Supplement 1):932-P   Crossref logo
Link1

Does A1c consistently reflect mean plasma glucose?
Journal of Diabetes. 2010;2(2):92-96   Crossref logo
Link1 Link2